These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21211679)

  • 1. [Contribution of genotyping in Fabry's disease].
    Froissart R; Piraud M; Maire I
    Rev Med Interne; 2010 Dec; 31 Suppl 2():S275-8. PubMed ID: 21211679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fabry disease: twenty-two novel mutations in the alpha-galactosidase A gene and genotype/phenotype correlations in severely and mildly affected hemizygotes and heterozygotes.
    Ashton-Prolla P; Tong B; Shabbeer J; Astrin KH; Eng CM; Desnick RJ
    J Investig Med; 2000 Jul; 48(4):227-35. PubMed ID: 10916280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Fabry's disease by the screening of alpha-galactosidase A activity in male and female hemodialysis patients.
    Tanaka M; Ohashi T; Kobayashi M; Eto Y; Miyamura N; Nishida K; Araki E; Itoh K; Matsushita K; Hara M; Kuwahara K; Nakano T; Yasumoto N; Nonoguchi H; Tomita K
    Clin Nephrol; 2005 Oct; 64(4):281-7. PubMed ID: 16240899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two novel alpha-galactosidase A mutations causing Fabry disease: A missense mutation M11V in a heterozygote woman and a nonsense mutation R190X in a hemizygote man.
    Celtikci B; Topçu M; Ozkara HA
    Clin Biochem; 2011 Jul; 44(10-11):809-12. PubMed ID: 21569769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of symptomatic heterozygous female Fabry's disease without detectable mutation in the alpha-galactosidase gene.
    Handa Y; Yotsumoto S; Isobe E; Sai Y; Yoshii N; Nakao S; Fujita N; Hamaguchi S; Kanzaki T
    Dermatology; 2000; 200(3):262-5. PubMed ID: 10828639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular genetic, biochemical, and clinical studies in three families with cardiac Fabry's disease.
    Yoshitama T; Nakao S; Takenaka T; Teraguchi H; Sasaki T; Kodama C; Tanaka A; Kisanuki A; Tei C
    Am J Cardiol; 2001 Jan; 87(1):71-5. PubMed ID: 11137837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An atypical variant of Fabry's disease in men with left ventricular hypertrophy.
    Nakao S; Takenaka T; Maeda M; Kodama C; Tanaka A; Tahara M; Yoshida A; Kuriyama M; Hayashibe H; Sakuraba H
    N Engl J Med; 1995 Aug; 333(5):288-93. PubMed ID: 7596372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fabry disease: data from four families].
    Slee PH; van Boven LJ; Slee DS
    Ned Tijdschr Geneeskd; 2000 Dec; 144(50):2412-5. PubMed ID: 11145098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Megadolichobasilar anomaly with thrombosis in a family with Fabry's disease and a novel mutation in the alpha-galactosidase A gene.
    Garzuly F; Maródi L; Erdös M; Grubits J; Varga Z; Gelpi E; Rohonyi B; Mázló M; Molnár A; Budka H
    Brain; 2005 Sep; 128(Pt 9):2078-83. PubMed ID: 15947062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Japanese patients with Fabry disease predominantly showing cardiac and neurological manifestation with novel missense mutation: R220P.
    Fukutomi M; Tanaka N; Uchinoumi H; Kanemoto M; Nakao F; Yamada J; Kamei T; Takenaka T; Fujii T
    J Cardiol; 2013 Jul; 62(1):63-9. PubMed ID: 23608164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-blood alpha-D-galactosidase A activity for the identification of Fabry's patients.
    Massaccesi L; Burlina A; Baquero CJ; Goi G; Burlina AP; Tettamanti G
    Clin Biochem; 2011 Jul; 44(10-11):916-21. PubMed ID: 21515249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fabry's disease (alpha-galactosidase-A deficiency): physiopathology, clinical signs, and genetic aspects].
    Germain DP
    J Soc Biol; 2002; 196(2):161-73. PubMed ID: 12360745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gaucher's and Fabry's diseases: biochemical and genetic aspects].
    Caillaud C; Poenaru L
    J Soc Biol; 2002; 196(2):135-40. PubMed ID: 12360742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights in cardiac structural changes in patients with Fabry's disease.
    Linhart A; Palecek T; Bultas J; Ferguson JJ; Hrudová J; Karetová D; Zeman J; Ledvinová J; Poupetová H; Elleder M; Aschermann M
    Am Heart J; 2000 Jun; 139(6):1101-8. PubMed ID: 10827394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High incidence of thrombosis in Fabry's disease.
    Utsumi K; Yamamoto N; Kase R; Takata T; Okumiya T; Saito H; Suzuki T; Uyama E; Sakuraba H
    Intern Med; 1997 May; 36(5):327-9. PubMed ID: 9213168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fabry disease in light of recent review].
    Uyama E
    Brain Nerve; 2008 Nov; 60(11):1235-44. PubMed ID: 19069157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetics of Fabry disease: diagnostic and therapeutic implications].
    Germain DP
    Presse Med; 2007 Mar; 36 Spec No 1():1S14-9. PubMed ID: 17546762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fabry disease: twenty novel alpha-galactosidase A mutations and genotype-phenotype correlations in classical and variant phenotypes.
    Germain DP; Shabbeer J; Cotigny S; Desnick RJ
    Mol Med; 2002 Jun; 8(6):306-12. PubMed ID: 12428061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [alpha-Galactosidase gene mutation and its expression product in Fabry disease (alpha-galactosidase deficiency)].
    Okumiya T; Takata T; Sasaki M; Sakuraba H
    Rinsho Byori; 1997 Feb; 45(2):127-35. PubMed ID: 9120996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Renal lesions in patients with Fabry's disease].
    Gubler MC
    Rev Med Interne; 2010 Dec; 31 Suppl 2():S220-5. PubMed ID: 21211668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.